Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 May 7;23:91. doi: 10.1186/s12943-024-01998-w

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2024

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

PMC Copyright notice

Fig. 5 — miR-30a-3p plays a tumor suppressor role in NSCLC with Osimertinib resistance. A Successful establishment of miR-30a-3p overexpression and knockdown cellular models: miR-30a-3p mimic and inhibitor and subsequently stably transfected them into PC9/OR and HCC827/OR cells, respectively. The transfection efficiency was assessed by RT-qPCR. B Cell counting kit-8 (CCK8) assay was conducted to determine the IC50 value of Osimertinib. C Soft agar colony assay was employed to assess colony formation ability. D Transwell chamber assay was performed to analyze cell invasion ability. F and Annexin V-FITC/PI assay was performed to investigate cell apoptosis. *P < 0.05, **P < 0.01. Osimertinib Sensitive; OR: Osimertinib Resistance. circ_100696: circ_PPAPDC1A